Thyroid stimulating hormone downregulates vascular endothelial growth factor expression in FRTL-5 cells

Thyroid

Volumn 11, Issue 6, 2001, Pages 539-543

  Miyagi, E ^a   Katoh, R ^a   Li, X ^a   Lu, S ^a   Suzuki, K ^a,b   Maeda, S ^c   Shibuya, M ^d   Kawaoi, A ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b MEDSTAR RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF YAMANASHI   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; THYROTROPIN; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DOWN REGULATION; MESSENGER RNA SYNTHESIS; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0034955782     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/105072501750302831     Document Type: Article

References (34)

1. Angiogenesis: A dynamic balance of stimulators and inhibitors
2. Regulators of angiogenesis
3. Angiogenic factors
4. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
5. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
6. Vascular endothelial growth factor is a secreted angiogenic mitogen
7. Vascular permeability factor, an endothelial cell mitogen related to PDGF
8. Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor
9. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
10. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis
11. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium
12. Retinoids downregulate vascular endothelial growth factor/vascular permeability factor production by normal human keratinocytes
13. Angiostatin suppresses malignant glioma growth in vivo
14. Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is downregulated by corticosteroids
15. Stimulation by thyroid-stimulating hormone and Grave's immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and fit mRNA expression in the rat thyroid in vivo
16. Thyroid-stimulating hormone promotes the secretion of vascular endothelial growth factor in thyroid cancer cell lines
17. Thyroglobulin: A master regulator of follicular function via transcriptional suppression of thyroid specific genes
18. Follicular thyroglobulin suppresses Iodide uptake by suppressing expression of the Sodium/Iodide symporter gene
19. Culture of hormone-dependent functional epithelial cells from rat thyroids
20. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA
21. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing
22. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms
23. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines
24. Differential expression of vascular endothelial growth factor (vascular permeability factor) forms in rat tissues
25. VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix
26. Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Ha-ras Tg. AC transgenic mice and FVB/N mice
27. 121) produced by Saccharomyces cerevisiae promotes both angiogenesis and vascular permeability
28. 165 using several concurrent mechanisms
29. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms
30. Short report: Identification of a specific pattern of vascular endothelial growth factor mRNA expression in human placenta and cultured placental fibroblasts
31. Transient neonatal hypothyroidism due to transplacental transfer of maternal immunoglobulins that inhibit TSH binding, TSH-induced cAMP increase and cell growth
32. In vivo expression of thyroid transcription factor-1 (TTF-1) RNA and its relation to thyroid function and follicular heterogeneity: Identification of follicular thyroglobulin as a feedback suppressor of thyroid transcription factor-1 RNA levels and thyroglobulin synthesis
33. Thyroglobulin regulates follicular function and heterogeneity by suppressing thyroid-specific gene expression
34. Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of Iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells